Eligibility criteria
Condition
Candidiasis
Sex
Females and Males
Age
18 + years
Inclusion criteria
Show details
- Positive culture plus at least one clinical sign and symptom consistent with invasive
candidiasis preferably within 96 hours of the proposed first dose of study drug
- Life expectancy: greater than 72 hours
Exclusion criteria
Show details
- Pregnant Females
- Treatment with other investigational drug(s) within 4 weeks
- Hypersensitivity to anidulafungin or echinocandin therapy
- Hypersensitivity to Tween 80 (polysorbate 80) or tartaric acid